Cutler Group’s Surmodics SRDX Stock Holding History

Cutler Group’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-601	Closed	-$15K	–	7161
2016 Q4	$15K	Buy	+601	New	+$15.8K	﹤0.01%	3774
2016 Q2	–	Sell	-140	Closed	-$2K	–	7246
2016 Q1	$2K	Sell	140 -997	-88%	-$18.8K	﹤0.01%	5659
2015 Q4	$23K	Buy	+1,137	New	+$24.1K	﹤0.01%	3286

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Teton Advisors Rye, New York $173M AUM 77.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cutler Group's SRDX Position: Q1 2017 in Review

Cutler Group sold out of Surmodics (SRDX) in Q1 2017, closing a stake of 601 shares — an estimated $15K sold.

Cutler Group first reported a position in SRDX in Q4 2015 and held it in 3 quarters. The position peaked at $23K in Q4 2015. 111 funds tracked by Wall St. Rank hold SRDX as of Q1 2017.

Cutler Group reported no remaining Surmodics position as of Q1 2017 after selling out during the quarter.
Cutler Group sold 601 Surmodics shares in Q1 2017, an estimated $15K.
Cutler Group first reported a position in Surmodics in Q4 2015 and held it in 3 quarters.
Cutler Group's Surmodics position peaked at $23K in Q4 2015.
111 funds tracked by Wall St. Rank held Surmodics as of Q1 2017.

Based on Cutler Group's 13F filing for Q1 2017, filed 11 Apr 2017.